Orthotopic Liver Transplantation for Hepatocellular Carcinoma: One Center's Experience in the Northeast of Brazil

Transplantation Proceedings

Volumn 41, Issue 5, 2009, Pages 1740-1742

  Coelho, G R ^a   Vasconcelos, K F ^a   Vasconcelos, J B M ^a   Barros, M A P ^a   Costa, P E G ^a   Borges, G C O ^a   Junior J T V ^a   Brasil, I R C ^a   Filho, D H C ^a   Viana, C F G ^a   Rocha, T D S ^a   Mesquita, D F ^a   Garcia, J H P ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA FETOPROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CANCER INVASION; CANCER RISK; CLINICAL ARTICLE; EXPLANT; FEMALE; HEPATITIS C VIRUS; HISTOLOGY; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; TUMOR RECURRENCE;

ADOLESCENT; ADULT; AGED; BRAZIL; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS C; HUMANS; LIVER CIRRHOSIS, ALCOHOLIC; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 67249119973     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.01.104     Document Type: Article

References (18)

1. Parkin D.M., Bray F., Ferlay J., et al. Estimating the world cancer burden: Globocan 2000. Int J Cancer 94 (2001) 153
2. Fattovich G., Stoffolini T., Zagni I., et al. Hepatocellular carcinoma in cirrhosis: incidence and risk factors. Gastroenterology 127 suppl 1 (2004) S35
3. Varela M., Sanchez W., Bruix J., et al. Hepatocellular carcinoma in the setting of liver transplantation. Liver Transpl 12 (2006) 1028
4. Llovet J.M., Schwartz M., and Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 25 (2005) 181
5. Jonas S., Bechstein W.O., Steinmuller T., et al. Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33 (2001) 1080
6. Mazzaferro V., Regalia E., Doci R., et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334 (1996) 693
7. El Serag H.B., and Mason A.C. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 340 (1999) 745
8. Deuffic S., Poynard T., Buffat L., et al. Trends in primary liver cancer. Lancet 351 (1998) 214
9. Stroffolini T., Andreone P., Andriulli A., et al. Characteristics of hepatocellular carcinoma in Italy. J Hepatol 29 (1998) 944
10. Taylor-Robinson S.D., Foster G.R., Arora S., et al. Increase in primary liver cancer in the UK, 1979-94. Lancet 350 (1997) 1142
11. Bosch F.X., Ribes J., Diaz M., et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology 127 5 suppl 1 (2004) S5
12. Cormier J.N., Thomas K.T., Chari R.S., et al. Management of hepatocellular carcinoma. J Gastrointest Surg 10 (2006) 761
13. Bruix J., and Llovet J.M. Management of hepatocellular carcinoma. Hepatology 42 (2005) 1208
14. Hasssan M.M., Hwang L.Y., Hatten C.J., et al. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 36 (2002) 1206
15. Zhang B.H., Yang B.H., and Tang Z.Y. Randomized controlled trial of screening for hepatocellular carcinoma. J Cancer Res Clin Oncol 130 (2004) 417
16. Trevisani F., D'Intino P.E., Morselli-Labate A.M., et al. Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. J Hepatol 34 (2001) 570
17. Ioannou G.N., Perkins J.D., and Carithers Jr. R.L. Liver transplantation for hepatocellular carcinoma: impact of the MELD allocation system and predictors of survival. Gastroenterology 134 (2008) 1342
18. Llovet J.M., Ricci S., Mazzaferro V., et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 359 (2008) 378